Navigation Links
Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
Date:2/14/2011

SAN LEANDRO, Calif., Feb. 14, 2011 /PRNewswire/ -- Mercator MedSystems, Inc., a privately held medical technology company focused on treating drug-resistant hypertension, announced today that Neil P. Desai, Ph.D. was elected to its Board of Directors. Dr. Desai has an extensive background in drug-delivery and global development and holds over 100 patents in the field. Prior to the acquisition of Abraxis Bioscience, Inc. (ABI), by Celgene Corporation in late 2010, he was Senior Vice-President of Global Research and Development for ABI where he was responsible for the development of ABI's proprietary product pipeline and intellectual property portfolio. He is presently Vice-President of Strategic Platforms at Celgene Corporation.

"Dr. Desai's extensive experience in drug development, global clinical research, and commercialization in an entrepreneurial environment is a perfect addition to Mercator's Board as we move to the next development stage of our unique approach to treating drug-resistant hypertension," said Thomas M. Loarie, Executive Chairman of Mercator MedSystems, Inc. Loarie also noted that this came at an ideal time with investor and strategic interest growing in hypertension treatments following the recent acquisition of Ardian, Inc., by Medtronic, Inc.

"I have been working with Mercator for over three years on collaborations using products developed by Abraxis so I have had a front row seat observing the development of their proprietary site-specific drug delivery platform," said Dr. Neil Desai. He added, "It's an exciting time in the evolution of Mercator and I am delighted to become a contributor."

Last year, pre-clinical data were presented on Mercator's therapeutic approach to drug-resistant hypertension and clinical data were presented on Athersys' use of Mercator's technology to deliver stem cells post-myocardial infarction at the 2010 Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.

About Mercator MedSystems, Inc.

Mercator MedSystems, Inc., based in San Leandro, Calif., is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery of therapeutic agents for applications in hypertension, cardiovascular disease, oncology and regenerative medicine.


'/>"/>
SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Relievant Medsystems Announces Completion of $20 Million Financing
2. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
3. Plato BioPharma, Inc Appoints New Board Member
4. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
5. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
6. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
7. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
10. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
11. Sysmex America Appoints Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
Breaking Medicine Technology:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):